EMP2 Antikörper (AA 22-66)
-
- Target Alle EMP2 Produkte
- EMP2 (Epithelial Membrane Protein 2 (EMP2))
-
Bindungsspezifität
- AA 22-66
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EMP2 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Epithelial membrane protein 2 protein (22-66AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- EMP2 (Epithelial Membrane Protein 2 (EMP2))
- Andere Bezeichnung
- EMP2 (EMP2 Produkte)
- Synonyme
- MGC52916 antikoerper, MGC130799 antikoerper, MGC69514 antikoerper, emp2 antikoerper, XMP antikoerper, epithelial membrane protein 2 L homeolog antikoerper, epithelial membrane protein 2 antikoerper, emp2.L antikoerper, emp2 antikoerper, EMP2 antikoerper, Emp2 antikoerper
- Hintergrund
-
Background: Functions as a key regulator of cell membrane composition by regulating proteins surface expression. Also, plays a role in regulation of processes including cell migration, cell proliferation, cell contraction and cell adhesion. Negatively regulates caveolae formation by reducing CAV1 expression and CAV1 amount by increasing lysosomal degradation (PubMed:24814193). Facilitates surface trafficking and formation of lipid rafts bearing GPI-anchor proteins (By similarity). Regulates surface expression of MHC1 and ICAM1 proteins increasing susceptibility to T-cell mediated cytotoxicity (By similarity). Regulates the plasma membrane expression of the integrin heterodimers ITGA6-ITGB1, ITGA5-ITGB3 and ITGA5-ITGB1 resulting in modulation of cell-matrix adhesion (PubMed:16216233). Also regulates many processes through PTK2. Regulates blood vessel endothelial cell migration and angiogenesis by regulating VEGF protein expression through PTK2 activation (PubMed:23439602). Regulates cell migration and cell contraction through PTK2 and SRC activation (PubMed:21637765, PubMed:22728127). Regulates focal adhesion density, F-actin conformation and cell adhesion capacity through interaction with PTK2 (PubMed:19494199). Positively regulates cell proliferation (PubMed:24814193). Plays a role during cell death and cell blebbing (PubMed:12107182). Promotes angiogenesis and vasculogenesis through induction of VEGFA via a HIF1A-dependent pathway (PubMed:23334331). Also plays a role in embryo implantation by regulating surface trafficking of integrin heterodimer ITGA5-ITGB3 (PubMed:16487956). May play a role in glomerular filtration (By similarity).
Aliases: EMP 2 antibody, EMP-2 antibody, EMP2 antibody, EMP2_HUMAN antibody, Epithelial membrane protein 2 antibody, Protein XMP antibody
- UniProt
- P54851
-